IASLC’s Time Capsule – Google Drive
No files in this folder. Sign in to add files to this
No files in this folder. Sign in to add files to this
Here, we summarize key findings from the final analysis of the LocoMMotion study, presented by Moreau et al. at the 50th Annual Meeting of the…
The FDA has withdrawn the approval of infigratinib for previously treated, FGFR2-positive, advanced cholangiocarcinoma.
A real-world study dives into treatment sequencing data and indicates most patients with HER2-positive metastatic breast cancer discontinued second-line treatment in the US.
Patrick Ott, MD, PhD, discusses the investigation of cancer vaccines, highlighting the clinical implications of this treatment modality in melanoma.
This cohort study evaluates whether the overall population of patients with metastatic cancer receiving care at practices with higher rates of oncologic therapy for very…
The AACR issues a call to action and cites progress, needed improvements, and key statistics in their Cancer Disparities Progress Report 2024.
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization Center for Childhood Cancer Research,…
Ali Bazarbachi, MD, PhD, American University of Beirut, Beirut, Lebanon, discusses the use of haploidentical stem cell transplantation (haploSCT) in treating non-Hodgkin lymphoma (NHL) and…
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
TSP is a reliable marker of clinical outcome measures, including platinum chemoresistance, PFS, and OS, in high-grade serous ovarian cancer.